Dual Biologic Therapy in an Adolescent With Camurati-Engelmann Disease and Crohn Disease

Camurati-Engelmann disease (CED) is a rare disorder caused by activating mutations in the TGF-β1 gene and characterized by hyperostosis of long bones and bone dysplasia. We describe a case of an adolescent with CED and moderate-severe Crohn Disease (CD). Infliximab improved gastrointestinal symptoms...

Descripción completa

Detalles Bibliográficos
Autores principales: Sami, Ahmad Salah, Rosh, Joel R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins, Inc. 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10158315/
https://www.ncbi.nlm.nih.gov/pubmed/37168741
http://dx.doi.org/10.1097/PG9.0000000000000169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10158315/
https://www.ncbi.nlm.nih.gov/pubmed/37168741
http://dx.doi.org/10.1097/PG9.0000000000000169

Ejemplares similares